Bryan T. Vaughn - 01 Jul 2026 Form 4 Insider Report for LABCORP HOLDINGS INC. (LH)

Reporting relationship: EVP and President, Diagnostics
Issuer ticker: LH
Reported as of: 01 Jul 2026
Net transaction value: -$66,968
SEC form: 4
Accepted by SEC: 06 Jul 2026, 09:36:47 UTC
Prior SEC filing: 30 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Kathryn W. Kyle, Attorney-in-Fact for Bryan T. Vaughn

Key filing fact

Bryan T. Vaughn filed Form 4 for LABCORP HOLDINGS INC. (LH) on 06 Jul 2026.

Key facts

This page summarizes Bryan T. Vaughn's Form 4 filing for LABCORP HOLDINGS INC. (LH).
4 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 06 Jul 2026, 09:36.

Change

Previous filing in this sequence was filed on 30 Mar 2026.
Current net transaction value: -$66,968.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002103999 Primary reporting owner

Vaughn Bryan T

Relationship: EVP and President, Diagnostics
Address: 531 SOUTH SPRING STREET, BURLINGTON
Signature: /s/ Kathryn W. Kyle, Attorney-in-Fact for Bryan T. Vaughn
Signature date: 06 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LH transaction

Common Stock

Options Exercise

Transaction value
Shares: +327
Change %: +4.8%
Price
Shares after: 7,073
Date: 01 Jul 2026
Ownership: Direct
Footnotes: F1

LH transaction

Common Stock

Tax liability

Transaction value
Shares: -93
Change %: -1.3%
Price: $283.88^*
Shares after: 6,980
Date: 01 Jul 2026
Ownership: Direct
Footnotes: F2

LH transaction

Common Stock

Sale

Transaction value: $66,968
Shares: -234
Change %: -3.4%
Price: $286.19
Shares after: 6,746
Date: 02 Jul 2026
Ownership: Direct
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LH transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
Shares: -327
Change %: -8.1%
Price: $0.000000^*
Shares after: 3,704
Date: 01 Jul 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 327
Exercise price
Footnotes: F1, F4, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 5 footnotes

Footnote F1

Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

Footnote F2

Stock withholding to satisfy tax withholding obligations.

Footnote F3

Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

Footnote F4

The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on July 1, 2026.

Footnote F5

This number reflects the aggregate number of Restricted Stock Units held by the reporting person.